# LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
> **ANDA208454** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM INDS LTD · Approved 2020-05-28
## Drug
- **FDA Application Number:** ANDA208454
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** Linagliptin And Metformin Hydrochloride
- **Active ingredients:** LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SUN PHARM INDS LTD
- **First approval:** 2020-05-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208454)
---
*MORVS · CC0 1.0*